关注
Xin Xie(谢欣)
Xin Xie(谢欣)
Chengdu University of Traditional Chinese Medicine, University of British Columbia
在 cdutcm.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Organocatalytic Asymmetric Synthesis of Six‐Membered Carbocycle‐Based Spiro Compounds
X Xie, W Huang, C Peng, B Han
Advanced Synthesis & Catalysis 360 (2), 194-228, 2018
1142018
Asymmetric synthesis of a structurally and stereochemically complex spirooxindole pyran scaffold through an organocatalytic multicomponent cascade reaction
X Xie, C Peng, G He, HJ Leng, B Wang, W Huang, B Han
Chemical Communications 48 (85), 10487-10489, 2012
802012
Catalytic asymmetric synthesis of spiropyrazolones and their application in medicinal chemistry
X Xie, L Xiang, C Peng, B Han
The Chemical Record 19 (11), 2209-2235, 2019
652019
Oridonin: a review of its pharmacology, pharmacokinetics and toxicity
X Li, CT Zhang, W Ma, X Xie, Q Huang
Frontiers in pharmacology 12, 645824, 2021
632021
Organocatalytic tandem Morita–Baylis–Hillman–Michael reaction for asymmetric synthesis of a drug-like oxa-spirocyclic indanone scaffold
X Li, L Yang, C Peng, X Xie, HJ Leng, B Wang, ZW Tang, G He, L Ouyang, ...
Chemical Communications 49 (77), 8692-8694, 2013
382013
Organocatalytic Morita–Baylis–Hillman/Michael/Acetalization Cascade: Procedure‐Controlled Diastereodivergence in the Asymmetric Synthesis of Fully Substituted Tetrahydropyrans
B Han, X Xie, W Huang, X Li, L Yang, C Peng
Advanced Synthesis & Catalysis 356 (17), 3676-3682, 2014
342014
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
R Qin, FM You, Q Zhao, X Xie, C Peng, G Zhan, B Han
Journal of Hematology & Oncology 15 (1), 133, 2022
322022
Novel HSP90-PI3K dual inhibitor suppresses melanoma cell proliferation by interfering with HSP90-EGFR interaction and downstream signaling pathways
Q Zhao, HP Zhu, X Xie, Q Mao, YQ Liu, XH He, C Peng, QL Jiang, ...
International Journal of Molecular Sciences 21 (5), 1845, 2020
302020
Role of Licochalcone A in potential pharmacological therapy: A review
MT Li, L Xie, HM Jiang, Q Huang, RS Tong, X Li, X Xie, HM Liu
Frontiers in Pharmacology 13, 878776, 2022
282022
Evodiamine alleviates lipopolysaccharide‐induced pulmonary inflammation and fibrosis by activating apelin pathway
C Ye, N Zhang, Q Zhao, X Xie, X Li, HP Zhu, C Peng, W Huang, B Han
Phytotherapy Research 35 (6), 3406-3417, 2021
192021
Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors
W Huang, L Cai, C Chen, X Xie, Q Zhao, X Zhao, H Zhou, B Han, C Peng
Journal of Biomolecular Structure and Dynamics 34 (2), 341-351, 2016
192016
Discovery of spirooxindole–ferrocene hybrids as novel MDM2 inhibitors
J Mu, X Xie, S Xiong, Y Zhang, Y Wang, Q Zhao, H Zhu, W Huang, G He
Chinese Chemical Letters 32 (6), 1897-1901, 2021
182021
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
X Xie, T Yu, X Li, N Zhang, LJ Foster, C Peng, W Huang, G He
Signal Transduction and Targeted Therapy 8 (1), 335, 2023
132023
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
X Li, Q Liu, X Xie, C Peng, Q Pang, B Liu, B Han
Journal of Medicinal Chemistry 66 (3), 1700-1711, 2023
102023
Design and organocatalytic synthesis of spirooxindole–cyclopentene–isoxazole hybrids as novel MDM2–p53 inhibitors
X Xie, SS Xiong, X Li, H Huang, FB Wu, PF Shen, C Peng, G He, B Han
Organic Chemistry Frontiers 8 (8), 1836-1843, 2021
102021
Asymmetric synthesis of oxa-spirocyclic indanones with structural complexity via an organocatalytic Michael–Henry–acetalization cascade
X Xie, C Peng, HJ Leng, B Wang, ZW Tang, W Huang
Synlett 25 (01), 143-147, 2014
102014
Thought and methodology of toxicity-efficacy network integrated analysis of toxic Aconitum
B Han, W Huang, X Xie, C Peng
World Chin Med 12 (11), 2585-97, 2017
72017
Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity
Q Zhao, SS Xiong, C Chen, HP Zhu, X Xie, C Peng, G He, B Han
Frontiers in Oncology 12, 972372, 2022
62022
Role of potential bioactive metabolites from traditional Chinese medicine for type 2 diabetes mellitus: An overview
X Li, JJ Geng-Ji, YY Quan, LM Qi, Q Sun, Q Huang, HM Jiang, ZJ Sun, ...
Frontiers in Pharmacology 13, 1023713, 2022
52022
Targeting bromodomain-containing proteins: research advances of drug discovery
Z Pan, Y Zhao, X Wang, X Xie, M Liu, K Zhang, L Wang, D Bai, LJ Foster, ...
Molecular Biomedicine 4 (1), 13, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20